Vanguard Asset Management’s Royalty Pharma RPRX Stock Holding History
Bought
Maintained
Sold
Other funds holding RPRX
Vanguard Asset Management's RPRX Position: Q3 2026 in Review
Vanguard Asset Management increased its Royalty Pharma (RPRX) stake by 10% in Q3 2026, buying an estimated $5.64M and bringing the position to 1,028,113 shares worth $60M. The position accounts for 0.04% of the portfolio, ranked #380.
Vanguard Asset Management first reported a position in RPRX in Q1 2026 and has held it in 3 quarters since. 702 funds tracked by Wall St. Rank hold RPRX as of Q3 2026.
- Vanguard Asset Management held 1,028,113 shares of Royalty Pharma worth $60M as of Q3 2026.
- Vanguard Asset Management bought 95,569 Royalty Pharma shares in Q3 2026, an estimated $5.64M.
- Royalty Pharma made up 0.04% of Vanguard Asset Management's portfolio in Q3 2026, its #380 holding.
- Vanguard Asset Management first reported a position in Royalty Pharma in Q1 2026 and has held it in 3 quarters since.
- 702 funds tracked by Wall St. Rank held Royalty Pharma as of Q3 2026.
Based on Vanguard Asset Management's 13F filing for Q3 2026, filed 13 Nov 2026.